Moreover, the 36-month beta value for CLMT is 1.06. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for CLMT is 68.47M and currently, short sellers hold a 14.27% of that float. On April 09, 2025, CLMT’s average trading volume was 1.46M shares.
CLMT) stock’s latest price update
The stock price of Calumet Inc (NASDAQ: CLMT) has plunged by -10.29 when compared to previous closing price of 8.99, but the company has seen a -38.67% decline in its stock price over the last five trading sessions. prnewswire.com reported 2025-04-01 that INDIANAPOLIS, April 1, 2025 /PRNewswire/ — Calumet, Inc. (NASDAQ: CLMT) (the “Company,” “Calumet,” “we,” “our” or “us”) has successfully closed its previously announced sale of assets related to the industrial portion of its Royal Purple® business, for $110 million in cash to a wholly owned subsidiary of Lubrication Engineers, Inc., a portfolio company of Aurora Capital Partners. The assets sold related to Royal Purple’s high performance synthetic industrial product line including industrial gear lubricants, bio-environmental lubricants, stationary natural gas engine oils, hydraulic lubricants, and compressor oils, along with an exclusive license of the brand for industrial applications.
CLMT’s Market Performance
Calumet Inc (CLMT) has seen a -38.67% fall in stock performance for the week, with a -25.22% decline in the past month and a -62.15% plunge in the past quarter. The volatility ratio for the week is 17.31%, and the volatility levels for the past 30 days are at 9.09% for CLMT. The simple moving average for the last 20 days is -32.67% for CLMT stock, with a simple moving average of -53.50% for the last 200 days.
Analysts’ Opinion of CLMT
Many brokerage firms have already submitted their reports for CLMT stocks, with UBS repeating the rating for CLMT by listing it as a “Neutral.” The predicted price for CLMT in the upcoming period, according to UBS is $12 based on the research report published on March 17, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see CLMT reach a price target of $16, previously predicting the price at $26. The rating they have provided for CLMT stocks is “Hold” according to the report published on March 04th, 2025.
UBS gave a rating of “Sell” to CLMT, setting the target price at $15 in the report published on February 04th of the current year.
CLMT Trading at -41.74% from the 50-Day Moving Average
After a stumble in the market that brought CLMT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.11% of loss for the given period.
Volatility was left at 9.09%, however, over the last 30 days, the volatility rate increased by 17.31%, as shares sank -27.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -46.04% lower at present.
During the last 5 trading sessions, CLMT fell by -38.40%, which changed the moving average for the period of 200-days by -50.09% in comparison to the 20-day moving average, which settled at $11.98. In addition, Calumet Inc saw -63.37% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CLMT starting from Mawer Stephen P, who sale 3,655 shares at the price of $12.88 back on Mar 24 ’25. After this action, Mawer Stephen P now owns 287,307 shares of Calumet Inc, valued at $47,076 using the latest closing price.
Mawer Stephen P, the Officer of Calumet Inc, proposed sale 3,655 shares at $12.77 during a trade that took place back on Mar 24 ’25, which means that Mawer Stephen P is holding shares at $46,671 based on the most recent closing price.
Stock Fundamentals for CLMT
Current profitability levels for the company are sitting at:
- 0.0 for the present operating margin
- 0.06 for the gross margin
The net margin for Calumet Inc stands at -0.05. The total capital return value is set at 0.0.
Based on Calumet Inc (CLMT), the company’s capital structure generated -0.64 points at debt to capital in total, while cash flow to debt ratio is standing at -0.17. The debt to equity ratio resting at -0.39. The interest coverage ratio of the stock is 0.03.
Currently, EBITDA for the company is 164.5 million with net debt to EBITDA at 2.23. When we switch over and look at the enterprise to sales, we see a ratio of 0.22. The receivables turnover for the company is 15.06for trailing twelve months and the total asset turnover is 1.52. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.89.
Conclusion
To wrap up, the performance of Calumet Inc (CLMT) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
